Compare EFOI & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EFOI | NOTV |
|---|---|---|
| Founded | 1985 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 10.8M |
| IPO Year | 2004 | 1997 |
| Metric | EFOI | NOTV |
|---|---|---|
| Price | $2.09 | $0.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 8.0K | ★ 746.0K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.75 | ★ 49.64 |
| EPS | ★ N/A | N/A |
| Revenue | $3,560,000.00 | ★ $547,656,000.00 |
| Revenue This Year | N/A | $5.28 |
| Revenue Next Year | N/A | $5.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 511.19 |
| 52 Week Low | $1.43 | $0.22 |
| 52 Week High | $3.56 | $3.31 |
| Indicator | EFOI | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 54.35 | 49.18 |
| Support Level | $1.94 | $0.25 |
| Resistance Level | $2.17 | $0.46 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 60.41 | 40.86 |
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.